BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2016.
World J Transplant. Sep 24, 2016; 6(3): 564-572
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.564
Figure 1
Figure 1 The Kaplan-Meier graft survival for the presence of performed donor-specific antibodies before transplant and newly formed (de novo) donor-specific antibodies after transplant. Patients with preformed donor-specific antibodies (DSA) had significantly lower graft survival than those without preformed DSA. The graft survival was markedly worse in patients with de novo DSA or persistent DSA.


Write to the Help Desk